VZV (gpIII) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-VZV (gpIII) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | VZV (gpIII) |
| Clone | [SG3] |
| Host Species | Mouse |
| Reactive Species | n/a |
| Isotype | IgG1, kappa |
| Format | Protein G purified |
| Size | 0.5 mg |
| Concentration | 1.16mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Varicella-Zoster Virus (VZV) (gpIII) (VZVgH). MAb to VZV (gpIII). Monoclonal Antibody to Varicella-Zoster Virus (VZV) |
| Immunogen | Immunogen: VZV Ellen Strain. Species Specificity: Reacts with VZV glycoprotein III. Immunofluorescence positive cells expressing VZV gp III show a strong green cytoplasmic fluorescence as well as cell membrane staining whereas, negative cells show a dark background of unstained cells. Precursor-products of VZV gp III produce bands at 100kDa-115kDa in Western blot. Affinity Constant: Not determined |
| Other Names | n/a |
| Gene, Accession # | [VZV] |
| Catalog # | MBS312709 |
| Price | $465 |
| Order / More Info | VZV (gpIII) Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Weller, T.H., (1979), Varicella and Herpes Zoster. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, (Lennette, E.H. and Schmidt, N.J., eds.) American Public Health Associations, Inc. Washington D.C., pp 375-398.2. Drew, W.L., et al., (1980), Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence, Am. J. Clin. Pathol., 73:699-701.3. Davison et al., (1986), New common nomenclature for glycoprotein gene of varicella-zoster virus and their glycosylated products, J. Virol., 57: 1195-1197. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies